Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease

Liang Zhang, Song Zhang, Izumi Maezawa, Sergey Trushin, Paras Minhas, Matthew Pinto, Lee Way Jin, Keshar Prasain, Thi D T Nguyen, Yu Yamazaki, Takahisa Kanekiyo, Guojun D Bu, Benjamin Gateno, Kyeong Ok Chang, Karl A Nath, Emirhan Nemutlu, Petras P Dzeja, Yuan-Ping Pang, Duy H. Hua, Eugenia D Trushina

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Development of therapeutic strategies to prevent Alzheimer's disease (AD) is of great importance. We show that mild inhibition of mitochondrial complex I with small molecule CP2 reduces levels of amyloid beta and phospho-Tau and averts cognitive decline in three animal models of familial AD. Low-mass molecular dynamics simulations and biochemical studies confirmed that CP2 competes with flavin mononucleotide for binding to the redox center of complex I leading to elevated AMP/ATP ratio and activation of AMP-activated protein kinase in neurons and mouse brain without inducing oxidative damage or inflammation. Furthermore, modulation of complex I activity augmented mitochondrial bioenergetics increasing coupling efficiency of respiratory chain and neuronal resistance to stress. Concomitant reduction of glycogen synthase kinase 3β activity and restoration of axonal trafficking resulted in elevated levels of neurotrophic factors and synaptic proteins in adult AD mice. Our results suggest that metabolic reprogramming induced by modulation of mitochondrial complex I activity represents promising therapeutic strategy for AD.

Original languageEnglish (US)
Pages (from-to)294-305
Number of pages12
JournalEBioMedicine
Volume2
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Alzheimer Disease
Animals
Animal Models
Modulation
Glycogen Synthase Kinase 3
Flavin Mononucleotide
AMP-Activated Protein Kinases
Nerve Growth Factors
Adenosine Monophosphate
Molecular Dynamics Simulation
Electron Transport
Amyloid
Energy Metabolism
Restoration
Neurons
Oxidation-Reduction
Molecular dynamics
Brain
Adenosine Triphosphate
Chemical activation

Keywords

  • Alzheimer's disease
  • AMPK
  • Amyloid beta
  • Animal models of familial AD
  • Axonal trafficking
  • Cellular energetics
  • GSK3beta
  • Hyperphosphorylated tau
  • Mitochondrial complex I activity

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease. / Zhang, Liang; Zhang, Song; Maezawa, Izumi; Trushin, Sergey; Minhas, Paras; Pinto, Matthew; Jin, Lee Way; Prasain, Keshar; Nguyen, Thi D T; Yamazaki, Yu; Kanekiyo, Takahisa; Bu, Guojun D; Gateno, Benjamin; Chang, Kyeong Ok; Nath, Karl A; Nemutlu, Emirhan; Dzeja, Petras P; Pang, Yuan-Ping; Hua, Duy H.; Trushina, Eugenia D.

In: EBioMedicine, Vol. 2, No. 4, 01.04.2015, p. 294-305.

Research output: Contribution to journalArticle

Zhang, L, Zhang, S, Maezawa, I, Trushin, S, Minhas, P, Pinto, M, Jin, LW, Prasain, K, Nguyen, TDT, Yamazaki, Y, Kanekiyo, T, Bu, GD, Gateno, B, Chang, KO, Nath, KA, Nemutlu, E, Dzeja, PP, Pang, Y-P, Hua, DH & Trushina, ED 2015, 'Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease', EBioMedicine, vol. 2, no. 4, pp. 294-305. https://doi.org/10.1016/j.ebiom.2015.03.009
Zhang, Liang ; Zhang, Song ; Maezawa, Izumi ; Trushin, Sergey ; Minhas, Paras ; Pinto, Matthew ; Jin, Lee Way ; Prasain, Keshar ; Nguyen, Thi D T ; Yamazaki, Yu ; Kanekiyo, Takahisa ; Bu, Guojun D ; Gateno, Benjamin ; Chang, Kyeong Ok ; Nath, Karl A ; Nemutlu, Emirhan ; Dzeja, Petras P ; Pang, Yuan-Ping ; Hua, Duy H. ; Trushina, Eugenia D. / Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease. In: EBioMedicine. 2015 ; Vol. 2, No. 4. pp. 294-305.
@article{62fa0dffef8149cf92786dcf8a52f224,
title = "Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease",
abstract = "Development of therapeutic strategies to prevent Alzheimer's disease (AD) is of great importance. We show that mild inhibition of mitochondrial complex I with small molecule CP2 reduces levels of amyloid beta and phospho-Tau and averts cognitive decline in three animal models of familial AD. Low-mass molecular dynamics simulations and biochemical studies confirmed that CP2 competes with flavin mononucleotide for binding to the redox center of complex I leading to elevated AMP/ATP ratio and activation of AMP-activated protein kinase in neurons and mouse brain without inducing oxidative damage or inflammation. Furthermore, modulation of complex I activity augmented mitochondrial bioenergetics increasing coupling efficiency of respiratory chain and neuronal resistance to stress. Concomitant reduction of glycogen synthase kinase 3β activity and restoration of axonal trafficking resulted in elevated levels of neurotrophic factors and synaptic proteins in adult AD mice. Our results suggest that metabolic reprogramming induced by modulation of mitochondrial complex I activity represents promising therapeutic strategy for AD.",
keywords = "Alzheimer's disease, AMPK, Amyloid beta, Animal models of familial AD, Axonal trafficking, Cellular energetics, GSK3beta, Hyperphosphorylated tau, Mitochondrial complex I activity",
author = "Liang Zhang and Song Zhang and Izumi Maezawa and Sergey Trushin and Paras Minhas and Matthew Pinto and Jin, {Lee Way} and Keshar Prasain and Nguyen, {Thi D T} and Yu Yamazaki and Takahisa Kanekiyo and Bu, {Guojun D} and Benjamin Gateno and Chang, {Kyeong Ok} and Nath, {Karl A} and Emirhan Nemutlu and Dzeja, {Petras P} and Yuan-Ping Pang and Hua, {Duy H.} and Trushina, {Eugenia D}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.ebiom.2015.03.009",
language = "English (US)",
volume = "2",
pages = "294--305",
journal = "EBioMedicine",
issn = "2352-3964",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease

AU - Zhang, Liang

AU - Zhang, Song

AU - Maezawa, Izumi

AU - Trushin, Sergey

AU - Minhas, Paras

AU - Pinto, Matthew

AU - Jin, Lee Way

AU - Prasain, Keshar

AU - Nguyen, Thi D T

AU - Yamazaki, Yu

AU - Kanekiyo, Takahisa

AU - Bu, Guojun D

AU - Gateno, Benjamin

AU - Chang, Kyeong Ok

AU - Nath, Karl A

AU - Nemutlu, Emirhan

AU - Dzeja, Petras P

AU - Pang, Yuan-Ping

AU - Hua, Duy H.

AU - Trushina, Eugenia D

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Development of therapeutic strategies to prevent Alzheimer's disease (AD) is of great importance. We show that mild inhibition of mitochondrial complex I with small molecule CP2 reduces levels of amyloid beta and phospho-Tau and averts cognitive decline in three animal models of familial AD. Low-mass molecular dynamics simulations and biochemical studies confirmed that CP2 competes with flavin mononucleotide for binding to the redox center of complex I leading to elevated AMP/ATP ratio and activation of AMP-activated protein kinase in neurons and mouse brain without inducing oxidative damage or inflammation. Furthermore, modulation of complex I activity augmented mitochondrial bioenergetics increasing coupling efficiency of respiratory chain and neuronal resistance to stress. Concomitant reduction of glycogen synthase kinase 3β activity and restoration of axonal trafficking resulted in elevated levels of neurotrophic factors and synaptic proteins in adult AD mice. Our results suggest that metabolic reprogramming induced by modulation of mitochondrial complex I activity represents promising therapeutic strategy for AD.

AB - Development of therapeutic strategies to prevent Alzheimer's disease (AD) is of great importance. We show that mild inhibition of mitochondrial complex I with small molecule CP2 reduces levels of amyloid beta and phospho-Tau and averts cognitive decline in three animal models of familial AD. Low-mass molecular dynamics simulations and biochemical studies confirmed that CP2 competes with flavin mononucleotide for binding to the redox center of complex I leading to elevated AMP/ATP ratio and activation of AMP-activated protein kinase in neurons and mouse brain without inducing oxidative damage or inflammation. Furthermore, modulation of complex I activity augmented mitochondrial bioenergetics increasing coupling efficiency of respiratory chain and neuronal resistance to stress. Concomitant reduction of glycogen synthase kinase 3β activity and restoration of axonal trafficking resulted in elevated levels of neurotrophic factors and synaptic proteins in adult AD mice. Our results suggest that metabolic reprogramming induced by modulation of mitochondrial complex I activity represents promising therapeutic strategy for AD.

KW - Alzheimer's disease

KW - AMPK

KW - Amyloid beta

KW - Animal models of familial AD

KW - Axonal trafficking

KW - Cellular energetics

KW - GSK3beta

KW - Hyperphosphorylated tau

KW - Mitochondrial complex I activity

UR - http://www.scopus.com/inward/record.url?scp=84942033298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942033298&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2015.03.009

DO - 10.1016/j.ebiom.2015.03.009

M3 - Article

AN - SCOPUS:84942033298

VL - 2

SP - 294

EP - 305

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

IS - 4

ER -